共 186 条
[5]
Ahrenkilde Hansen P., 2022, A cancer plan for Europe
[7]
Subcellular metabolite profiles of the parent CCRF-CEM and the derived CEM/C2 cell lines after treatment with doxorubicin
[J].
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES,
2004, 808 (02)
:295-302
[9]
Clinical Review: Navitoclax as a Pro-Apoptotic and Anti-Fibrotic Agent
[J].
FRONTIERS IN PHARMACOLOGY,
2020, 11